Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Trapman-Jansen AM"'
Autor:
Hammerl D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Timmermans M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Trapman-Jansen AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Isaeva OI; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Voorwerk L; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Balcioglu HE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Wijers R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Nederlof I; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Salgado R; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia., Horlings H; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.kok@nki.nl., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.debets@erasmusmc.nl.
Publikováno v:
Nature communications [Nat Commun] 2021 Sep 27; Vol. 12 (1), pp. 5668. Date of Electronic Publication: 2021 Sep 27.
Autor:
Liu NQ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., De Marchi T; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Timmermans A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Trapman-Jansen AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Look MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Span PN; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Sweep FC; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Brask JB; Department of Pathology, Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark., Timmermans-Wielenga V; Department of Pathology, Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Umar A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Scientific reports [Sci Rep] 2016 Aug 25; Vol. 6, pp. 32027. Date of Electronic Publication: 2016 Aug 25.
Autor:
Jansen MP; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Helmijr JC; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Marion R; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Krol NM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Rotterdam, The Netherlands., Monkhorst K; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Trapman-Jansen AM; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Meijer-van Gelder ME; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Weerts MJ; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ramirez-Ardila DE; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Foekens JA; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Berns EM; Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2016 Jul 12; Vol. 7 (28), pp. 43412-43418.
Autor:
van der Willik KD; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Timmermans MM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., van Deurzen CH; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands., Look MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Reijm EA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., van Zundert WJ; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Trapman-Jansen AM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., den Bakker MA; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical CenterRotterdam, The Netherlands; Department of Pathology, Maasstad HospitalRotterdam, The Netherlands., Westenend PJ; Laboratory for Pathology Dordrecht, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Berns EM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Jansen MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2016 Jan 15; Vol. 6 (2), pp. 270-84. Date of Electronic Publication: 2016 Jan 15 (Print Publication: 2016).
Autor:
Liu NQ; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands; §§Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands; ¶¶Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, 6525 GA, Nijmegen, The Netherlands., De Marchi T; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, §§Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands;, Timmermans AM; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., Beekhof R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., Trapman-Jansen AM; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., Foekens R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., Look MP; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., van Deurzen CH; §Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands;, Span PN; ¶Department of Radiation Oncology., Sweep FC; ‖Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;, Brask JB; *Department of Pathology, the Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark;, Timmermans-Wielenga V; *Department of Pathology, the Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark;, Debets R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute., Martens JW; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands;, Foekens JA; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands;, Umar A; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands; a.umar@erasmusmc.nl.
Publikováno v:
Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2014 Jul; Vol. 13 (7), pp. 1814-27. Date of Electronic Publication: 2014 Apr 17.
Autor:
Nagel JH; Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands., Peeters JK, Smid M, Sieuwerts AM, Wasielewski M, de Weerd V, Trapman-Jansen AM, van den Ouweland A, Brüggenwirth H, van I Jcken WF, Klijn JG, van der Spek PJ, Foekens JA, Martens JW, Schutte M, Meijers-Heijboer H
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Apr; Vol. 132 (2), pp. 439-48. Date of Electronic Publication: 2011 May 26.